www.fdanews.com/articles/87840-pharma-blog-watch
Pharma Blog Watch
June 23, 2006
New
T-Cell Lymphoma Treatment (The Pharm Voice)
In her entry, blogger Gloria
Gamat discusses Favrille's electronic investigational new drug (IND) application
for FAV-201, a patient-specific immunotherapy for the treatment of T-cell lymphoma.
Zocor
Goes Off-Patent (Patent Baristas)
Blogger Karlyn Schnapp discusses
the issues faced by Merck as its cholesterol medication Zocor going off-patent.